...
首页> 外文期刊>Journal of arrhythmia. >Molecular pathogenesis of long QT syndrome type 1
【24h】

Molecular pathogenesis of long QT syndrome type 1

机译:1型长QT综合征的分子发病机制

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Long QT syndrome type 1 (LQT1) is a subtype of a congenital cardiac syndrome caused by mutation in the KCNQ1 gene, which encodes the @a-subunit of the slow component of delayed rectifier K^+ current (I"K"s) channel. Arrhythmias in LQT1 are characterized by prolongation of the QT interval on ECG, as well as the occurrence of life-threatening cardiac events, frequently triggered by adrenergic stimuli (e.g., physical or emotional stress). During the past two decades, much advancement has been made in understanding the molecular pathogenesis underlying LQT1. Uncovering the genotype-phenotype correlations in LQT1 is of clinical importance to better understand the gene-specific differences that may influence the propensity for developing life-threatening arrhythmias under specific conditions. Elucidation of these mechanisms will also help to improve the diagnosis and management of this cardiac disorder based on gene-specific considerations. This review describes the current medical consensus and recent developments regarding the molecular pathogenesis of LQT1 and provides a novel insight into the adrenergic regulation of this disease.
机译:1型长QT综合征(LQT1)是由KCNQ1基因突变引起的先天性心脏病综合征的亚型,该基因编码延迟整流K ^ +电流(I“ K” s)通道慢成分的@ a-亚基。 LQT1的心律不齐的特征是ECG的QT间隔延长,以及经常发生由肾上腺素能刺激(例如身体或情绪压力)触发的威胁生命的心脏事件。在过去的二十年中,在理解LQT1的分子发病机理方面取得了很大的进步。揭示LQT1中的基因型-表型相关性对于更好地了解可能在特定条件下发展威胁生命的心律不齐的倾向的基因特异性差异具有临床重要性。基于基因特异性的考虑,阐明这些机制也将有助于改善这种心脏病的诊断和治疗。这篇综述描述了有关LQT1分子发病机制的当前医学共识和最新进展,并提供了对该疾病的肾上腺素调节的新见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号